VNSAX
Price
$22.89
Change
+$0.10 (+0.44%)
Updated
Jul 2 closing price
Net Assets
566.77M
VTSMX
Price
$148.71
Change
+$0.80 (+0.54%)
Updated
Jul 2 closing price
Net Assets
1.82T
Interact to see
Advertisement

VNSAX vs VTSMX

Header iconVNSAX vs VTSMX Comparison
Open Charts VNSAX vs VTSMXBanner chart's image
Natixis Vaughan Nelson Select A
Price$22.89
Change+$0.10 (+0.44%)
VolumeN/A
Net Assets566.77M
Vanguard Total Stock Mkt Idx I
Price$148.71
Change+$0.80 (+0.54%)
VolumeN/A
Net Assets1.82T
VNSAX vs VTSMX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VNSAX vs. VTSMX commentary
Jul 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VNSAX is a Buy and VTSMX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSMX has more cash in the bank: 1.82T vs. VNSAX (567M). VTSMX pays higher dividends than VNSAX: VTSMX (1.12) vs VNSAX (0.00). VNSAX was incepted earlier than VTSMX: VNSAX (13 years) vs VTSMX (33 years). VNSAX (1.13) is less costly to investors than VTSMX (0.14). VNSAX is a more actively managed with annual turnover of: 84.00 vs. VTSMX (2.00). VNSAX has a lower initial minimum investment than VTSMX: VNSAX (2500) vs VTSMX (3000). VTSMX annual gain was more profitable for investors over the last year : 13.54 vs. VNSAX (8.50). VTSMX return over 5 years is better than : 92.98 vs. VNSAX (31.49).
VNSAXVTSMXVNSAX / VTSMX
Total Expense Ratio1.100.14786%
Annual Report Gross Expense Ratio1.130.14807%
Fund Existence13 years33 years-
Gain YTD5.4975.002110%
Front Load6%N/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets567M1.82T0%
Annual Yield % from dividends0.001.12-
Returns for 1 year8.5013.5463%
Returns for 3 years39.9559.9267%
Returns for 5 years31.4992.9834%
Returns for 10 years54.12193.0128%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MESO12.121.23
+11.29%
Mesoblast Limited
FULTP18.200.10
+0.55%
Fulton Financial Corp
HRTX2.07N/A
N/A
Heron Therapeutics
DY244.32-0.07
-0.03%
Dycom Industries
PRT4.05-0.14
-3.34%
PermRock Royalty Trust Trust